the importance of understanding tki-specific side effects to select the best option for each patient
Published 2 years ago • 125 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
1:40
tki dosage: should clinicians stick to the product monograph recommendations?
-
2:39
managing the potential cardiotoxicity associated with btkis: important considerations
-
0:58
current research and next steps to improve the understanding and management of icaht
-
1:32
factors contributing to the pathogenesis of icaht
-
2:30
tti-621 for hematologic malignancies: a phase i dose escalation and expansion study
-
1:47
unmet needs in wm: managing high-risk disease, sequencing novel agents, & personalizing treatment
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
5:37
hemostasis | how we stop bleeding
-
14:24
the theory of everything
-
1:59
treating r/r cll: the value of btkis and venetoclax
-
1:47
shared treatment decision-making
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:41
isct in bringing together the scientific community
-
1:06
origins and treatment options for anemia in myelofibrosis
-
1:02
maintenance therapy following treatment for amyloidosis
-
3:40
outcomes of all stratified by socioeconomic factors
-
1:05
the future of managing precursor conditions
-
3:19
supportive care in al amyloidosis
-
1:45
a phase ii study of elritercept for lower-risk mds
-
1:20
improving outcomes of non-covalent btki treatment
-
0:47
novel agents being explored for the treatment of immune-mediated ttp